Neuromuscular Study Group Inc (EIN 474456205) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

Mazen Dimachkie MD

Tax Period

2024-01-01 to 2024-12-31

Neuromuscular Study Group Inc, founded in 2015, is a small nonprofit in the Medical Research sector that reported $589K in total revenue in fiscal year 2024. Revenue surged 36% from the prior year, signaling strong growth momentum. Expenses of $519K left a modest 12% surplus.

Mission

To advance knowledge about the cause(s), pathogenesis, epidemiology, and clinical manifestations of muscle disease and related neuromuscular disorders and to develop and implement strategies to examine promising therapeutic interventions

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $580,823

Investment Income $8,136

Other Revenue $0

TOTAL REVENUE $588,959

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $485,091

Other Expenses $519,092

TOTAL EXPENSES $519,092

Year-over-Year Comparison

	2024	2023	Change
Revenue	$588,959	$434,016	+0.4%
Expenses	$519,092	$462,062	+0.1%
Net Income	$69,867	$-28,046	-3.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
Amanda Guidon MD	Investigator Member	Director	$0	$0	$0
Michael Hehir MD	Investigator Member	Director	$0	$0	$0
John Vissing MD	Investigator Member	Director	$0	$0	$0
Michaela Walker MPH CCRP	Coordinator Member	Director	$0	$0	$0
Michael McDermott PhD	Biostatistician	Director	$0	$0	$0
Emma Ciafaloni MD FAAN	Director	Director	$0	$0	$0
James Lilleker MBChB MRCP PhD	Investigator Member	Director	$0	$0	$0
Bhaskar Roy MBB MHS	Young Investigator Member	Director	$0	$0	$0
Richard Barohn MD	Chair	Officer	$0	$0	$0
Michael Hanna MD	Co-Chair	Officer	$0	$0	$0
Mazen Dimachkie MD	Treasurer	Officer	$0	$0	$0
Liz Paulk	Secretary	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$588,959	$519,092	$530,512	$69,867
2023	$434,016	$462,062	$460,644	$-28,046
2022	$278,605	$425,917	$488,693	$-147,312
2021	$428,433	$192,454	$636,005	$235,979
2020	$284,473	$157,001	$400,026	$127,472
2019	$461,043	$371,388	$272,554	$89,655

Neuromuscular Study Group Inc